Quest Diagnostics to Acquire Laboratory Outreach Service Business
News Jul 01, 2015
Quest Diagnostics and MemorialCare Health System have announced they have entered into a definitive agreement for Quest to acquire MemorialCare Health System's laboratory outreach service business.
Under the agreement, MemorialCare Health System will transition its outreach laboratory testing to Quest's accredited full-service clinical laboratory in West Hills, California. MemorialCare Health System's hospital-based laboratories are not a part of the transaction. Once the acquisition is completed, patients and physicians will have access to Quest's broad menu of innovative services, including next generation sequencing, and Quest's network of nearly 200 patient service centers in southern California.
"We are excited about the opportunity to enable a larger number of physicians and patients in southern California to benefit from our diagnostic insights," said Steve Rusckowski, president and CEO, Quest Diagnostics. "This transaction underscores the attractiveness of Quest Diagnostics as a provider of high-quality, high-value diagnostic information services for hospital systems considering strategic alternatives for their outreach businesses."
The acquisition supports Quest's five-point strategy, which includes restoring growth and driving disciplined capital deployment through strategically aligned, accretive acquisitions. The transaction is expected to be neutral to earnings in 2015.
New Software Allows Mobile Monitoring of Breathing ProblemsNews
Researchers have developed new software that makes it possible to use low-cost, thermal cameras attached to mobile phones to track how fast a person is breathing.READ MORE
Agilent Announces Expanded Use of Cancer Diagnostic in the USNews
Agilent announced that the FDA has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma of the head and neck (SCCHN).READ MORE
Blood Test for Colitis Screening Could Reduce Dependence on ColonoscopyNews
A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy, which is now the predominant test.READ MORE
Comments | 0 ADD COMMENT
13th Edition of International Conference on Pediatric Gastroenterology
Aug 02 - Aug 04, 2018